Objectives: The nucleus accumbens (NAc) has recently been implicated in the pathophysiology of depression. In animals displaying depressive-like behavior following chronic stress exposure, glutamatergic transmission increases in the NAc. NMDA receptor antagonist ketamine act as an antidepressant, especially in treatment-resistant cases. In this study, we aimed to investigate the effects of single-dose ketamine application in the activation of cells in the NAc of prenatally stressed rats.
Introduction
Stressful experiences during pregnancy might lead to diverse consequences including neuroendocrine abnormalities, metabolic disorders, behavioral and cognitive problems in the offspring. [1, 2] Prenatal stress (PS) exposure disturbs the brain development of pups by altering expression of stress hormones, neurotransmitters and their receptors, [3, 4] activity of several ion channels [5] and synaptic formation. [6] Numerous studies have shown the effects of PS on the limbic structures, such as the hippocampus and the prefrontal cortex, [7, 8] whereas relatively little is known about effects on the other limbic structures. The nucleus accumbens (NAc) is the center of reward mood and motivation, but it has recently been implicated in the pathophysiology of depression especially via dopaminergic and glutamatergic alterations. [9] [10] [11] [12] As a major component of the ventral striatum, NAc extends dorsolaterally into the putamen and dorsomedially into the caudate nucleus. [13] The NAc contains a large number of γ-aminobutyric acid (GABA)-containing medium spiny projecting neurons (%95) and only a small populations of GABAergic and cholinergic interneurons. [14] The activity of medium spiny neurons is regulated by glutamatergic afferents coming from the prefrontal cortex, hippocampus and amygdala, dopaminergic Single dose ketamine injection affects activation of cells in the nucleus accumbens of prenatally stressed rats Elif Polat Çorumlu 1 afferents from the ventral tegmental area, as well as serotonergic and noradrenergic afferents from the raphe nucleus, and the locus ceruleus, respectively. [15] Thus, the NAc plays important roles in emotional control.
The NAc is divided into a central core surrounded by an outer shell area on its medial, ventral and ventrolateral sides. These two anatomically and functionally distinct subregions have diverse organizational patterns. [16] While the core region projects primarily to a restricted part of the globus pallidus and the substantia nigra; the shell region projects not only to the subcommissural part of the ventral pallidum and the ventral tegmental area (VTA), but also projects to widespread areas in the hypothalamus and extended amygdala. [15] Shell area contains substances such as calretinin, substance P, dopamine, and serotonin, while the core area contains calbindin, encephalin and GABA A receptors. Furthermore, Fos-like immunoreactivity is higher in the shell region of the NAc. [17] In animals displaying depression-like behavior following chronic stress exposure, glutamatergic transmission increases in the NAc. [18, 19] Intriguingly, susceptibility to depression is mediated by glutamatergic transmission from the ventral hippocampal afferents to NAc, but not from the medial prefrontal cortex or basolateral amygdala. [20] Because in vivo optogenetic manipulations of ventral hippocampus-NAc synaptic transmission cause depressivelike behaviors, while acute enhancement of glutamatergic input from either medial prefrontal cortex or basolateral amygdala attenuates transmission and promotes resilience. Recently, inhibition of glutamate release in subregions of the hippocampus and prefrontal cortex has been shown as a promising target in the treatment of patients who do not respond to classical antidepressants. It has been demonstrated that NMDA receptor antagonist ketamine shows such an antidepressant effect by rapidly stimulating the mammalian target of rapamycin (mTOR). [21] Ketamine reverses the deficits in synapse number and increases the levels of synaptic proteins reduced by chronic stress exposure. [22] It has also been shown that ketamine injection significantly increases dopamine [23, 24] and blood-oxygenationlevel-dependent (BOLD) levels [25] in the NAc after chronic stress. However, the effects of ketamine were not examined in the NAc following PS exposure. Previously, we have shown that ketamine treatment decreases c-Fos expressing cells in the medial prefrontal cortex of prenatally stressed rats. [26] Therefore, current study aims to investigate the effects of single-dose ketamine application in the NAc of prenatally stressed rats in a subregion specific manner.
Materials and Methods
Healthy Sprague-Dawley rats obtained from the breeding colony at the Eskiflehir Osmangazi University Animal Care Facility and maintained under constant temperature (21°C) and light (12:12 h light/dark cycle) conditions. After overnight mating, pregnancy was confirmed by the sperm positivity in the vaginal smear. Pregnant rats were housed individually in transparent cages by giving free access to food and tap water. Experimental procedures were performed in accordance with protocols approved by the Institutional Animal Usage Committee (Protocol #201/1). Dams (n=10) were immobilized in close-fitting wire mesh cylinders daily for 3 hours, between E14 and E21. At postnatal day 40, male offspring from control and prenatally stressed groups (n=20) received serum physiologic (CTRL+SF and PS+SF) or a single dose (10 mg/kg, i.p.) of ketamine injection (CTRL+ketamine and PS+ketamine) Animals were sacrificed two days after ketamine or SF injection. Forced swim procedure was used to stimulate neuronal activity for evaluation of the immediate gene expression. Animals were kept in an inescapable condition for 5 minutes, and then removed from the water, dried with towels, and sacrificed immediately via cardiac perfusion following halothane inhalation. Animals were perfused with phosphate-buffered saline (PBS) followed by 4% paraformaldehyde in 0.1 M phosphate buffer (pH=7.4). After dissection, brains were dehydrated in graded alcohols and embedded in paraffin. The brain tissue was sectioned at 5 μm thickness and every 30th section, obtained between Bregma 3.00 and 0.60 according to stereotaxic rat atlas by Paxinos and Watson, [27] was mounted on poly-L-lysine coated slides (Figure 1 ). Deparaffinized and rehydrated sections were treated with 0.3% H2O2 for 30 min, washed in PBS, and then boiled in antigen retrieval solution, containing sodium citrate (pH=6.00) for 5 min in a microwave oven. Unspecific binding was suppressed in a blocking solution for 30 min at room temperature. The rabbit polyclonal antibody to c-Fos (ABE457, Merck Millipore, Darmstadt, Germany) was used at 1:200 dilution. After overnight incubation at 4°C, sections were incubated in biotinylated anti-rabbit secondary antibody (1:100, Novostain Universal Detection Kit, Novocastra Laboratories, Newcastle upon Tyne, UK) for 30 min at room temperature. Bound antibody was detected by streptavidin/ peroxidase complex (PK-6100, ABC Elite Kit, Vector laboratories, Burlingame, CA, USA), and diaminobenzidine (DAB) mixture as chromogen. Finally, sections were dehydrated in alcohol series, cleared in xylene, and coverslipped with permanent mounting medium.
The total number of c-Fos (+) nuclei was quantified using the optical fractionator probe of Stereoinvestigator system (Version 11; Microbrightfield Inc., Williston, VT, USA). Blind-coded slides were investigated by applying systematic random sampling approach in every step. Outlines of the core and shell regions were delineated and all c-Fos (+) profiles within the two-dimensional counting frames (300 μm × 300 μm in size) were quantified under high power magnification. Size of the grid (400 μm × 400 μm × 10 μm) was set to sample 10-15 sites in each section and the optical dissector height was set at 3 μm. The coefficient of error was calculated according to Schmitz and Hof, and values less than 0.05 were considered acceptable.
Shapiro-Wilk and Kolmogorov-Smirnov tests were used to assess normality distribution of the data. One-way ANOVA followed by Tukey's multiple comparisons test was used to compare groups. Results were considered significant at a level of p<0.05. IBM SPSS (Statistical Package for the Social Sciences, version 21.0; IBM, Chicago, IL, USA) software was used for all the analyses.
Results
Stress-induced immediate gene expression was evaluated by using c-Fos immunohistochemistry. One-way ANOVA results displayed a significant group difference [F(3.9)= 11.04, p=0.0023] in the total number of nucleus accumbens. Total number of c-Fos (+) neurons in PS+SF group (2683×10 6 ) was significantly (p<0.05) lower than those of CTRL+SF group (5826×10 6 ), but ketamine injection significantly (p<0.01) enhanced the activation of cells in PS+ketamine group. Therefore, the activation of cells was comparable in CTRL groups treated with either ketamine or saline injection (Figure 3) .
Likewise the previous groups, activation of cells in the core area displayed a significant group difference [F(3.9)=7.438, p=0.0083]. However, in this subregion of the NAc prenatal stress exposure did not reduce the total number of c-Fos (+) cells. One-way ANOVA results showed that activation of cells in PS group was similar to CTRL groups treated with either SF or ketamine ( Figure  4) . Thus, group difference was due to enhancement ( 4986× 10 6 ). in the number of activated cells in ketamine-treated PS group.
Discussion
Stress exposure causes alterations in the morphology and activity of neurons in the mesocorticolimbic structures in a region specific manner. In this study, we showed that PS decreases the number of c-Fos (+) cells in NAc and a single dose ketamine treatment reverses this effect. Interestingly, the impact of prenatal stress exposure was seen only in the shell area, while ketamine treatment affected both core and shell subregions of the NAc.
Previous studies indicate that environmental factors might cause structural, functional, molecular, and epigenetic alterations in the NAc. [28] [29] [30] [31] Activation of the ventral hippocampus has an acute stimulatory effect on dopamine release in the shell of the NAC, while it has a suppressive effect on extracellular dopamine levels in the core subregion. [32] Volumetric changes might be seen in the NAc of depressive patients, although inconsistent results were reported in the literature. While most of the studies showed no alterations in the volume of the NAc in patients having major depression, [33, 34] some reports displayed reduction in its volume, especially in elderly patients. [35] On the other hand, in glutamate-based depression cases over activation of extrasynaptic NMDA receptors by glutamate causes NAc hypertrophy. [36] In addition, in these patients, an activity reduction could be seen in the whole ventral striatum area. [37, 38] Similar to our study's results, it has been shown that PS modulates the activity of NAc by decreasing the cell proliferation [39] and reducing the volume of NAc. [40] Likewise, stress and depression cause phasic activation of the VTA-NAc pathway and corelease dopamine and BDNF in the NAc region. [41] Ketamine infusion in rodents increases spontaneous activation of dopaminergic neurons in the VTA and extracellular dopamine level in the NAc. [42] These results imply that enhanced neuronal activation seen in the current study following ketamine treatment might be caused by dopaminergic system activation.
It is known that stressful events can induce gene expression by chromatin remodeling and histone modification, which then cause addiction behavior. As Schroeder et al. [43] pointed out, region-specific D1-receptor-regulated histone (phospho) acetylation affects gene expression and differentially regulates reward circuitry. Reus et al. [44] showed that ketamine treatment did not affect histone deacetylase (HDAC) activity in the prefrontal cortex, hippocampus and amygdala of maternally deprived adult rats. In contrast, there is an increased HDAC activity in the nucleus accumbens of deprived rat and it has been shown that ketamine treatment was able to reverse this alteration specifically in this region. Various NMDA receptor antagonists have been shown to enhance dopamine levels in the NAc in a subregionspecific manner. [45, 46] For example, phencyclidine (PCP) and dizocilpine (MK-801) significantly elevate extracellular dopamine levels in the shell subregion, but not cause alterations in the core subregion. Low doses of the another competitive NMDA receptor antagonist CGP 39551 failed to affect dopamine output in either region; while at higher doses it elevates the dopamine output in the shell compared to the core subregion. [47] It seems like, the effects of NMDA receptors and dopamine dysregulation are region specific by affecting predominantly the shell subregion of the NAc. [48] In our study, we observed that ketamine treatment enhanced the activation of cells in both shell and core regions. These differences might be related to the dose and action mechanisms of different NMDA receptor antagonists. As a matter of fact, it has been noted that ketamine acts differentially at higher or lower doses in terms of changing the basal firing rates of ventral tegmental DA neurons. [49] 
Conclusion
Current clinical and animal studies report that subanesthetic dose of ketamine produces antidepressant like effect especially in treatment-resistant patients. The effects of ketamine have been mostly investigated following acute or chronic stress exposure, but its effects in prenatal stress paradigm is not well understood. Our study showed that although PS particularly reduces the activation of the cells in the shell subregion, ketamine treatment could act on both core and shell regions by affecting glutamatergic limbic information that flows from shell to core subregion of the NAc.
